Annex

Annex I to Regulation (EEC) No 2377/90 is amended as follows:

1. (1)

   in point 1.2.4, the entry for ‘Acetylisovaleryltylosin’ is replaced by the following:

   1.2.4.

   Macrolides

   For porcine species, this MRL relates to “skin and fat in natural proportions”.
   Not for use in animals from which eggs are produced for human consumption.
   For poultry species, this MRL relates to “skin and fat in natural proportions”.’
   Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
   ‘Tylvalosin	Sum of tylvalosin and 3-O-acetyltylosin	Porcine	50 μg/kg	Muscle
   			50 μg/kg	Fatf1
   			50 μg/kg	Liver
   			50 μg/kg	Kidney
   		Poultryf2	50 μg/kg	Fatf3
   			50 μg/kg	Liver

2. (2)

   the following point 1.2.16 is added:

   ‘1.2.16.

   Ionophores

   For poultry species, this MRL relates to “skin and fat in natural proportions”.
   Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
   Monensin	Monensin A	Bovine	2 μg/kg	Muscle
   			10 μg/kg	Fat
   			30 μg/kg	Liver
   			2 μg/kg	Kidney
   			2 μg/kg	Milk
   Lasalocid	Lasalocid A	Poultry	20 μg/kg	Muscle
   			100 μg/kg	Fatf4
   			100 μg/kg	Liver
   			50 μg/kg	Kidney
   			150 μg/kg	Eggs

   ’

3. (3)

   in point 2.4.4, the entry for ‘Lasalocid’ is deleted.